James Walsh

Reporter | Medical Technology
Phone: 612-673-7428
James Walsh covers medical technology companies such as Medtronic and St. Jude and innovations.

Recent content from James Walsh

U finds doctor failed to disclose Medtronic work

Dr. David Polly received "cautionary letter" over work that paid more than $1M.

Updated: December 20, 2011, - 07:06 AM

New stroke therapy shows promise on kids

Using non-invasive electronic stimulation, coupled with occupational therapy, researchers say they are hoping kids can increase hand function.

Updated: December 18, 2011, - 02:18 PM

FDA recalls St. Jude's Riata defibrillator lead over risks

The company took the Riata defibrillator lead off the market last year.

Updated: December 16, 2011, - 08:10 AM

Kickback case costs Medtronic $23.5 million

Company denies impropriety after a federal investigation into payments made to doctors.

Updated: December 13, 2011, - 07:12 AM

From tragedy, a business opportunity to save lives

After a heart attack killed Marie Johnson's husband, she went to work on a detector.

Updated: December 10, 2011, - 10:07 PM

CardioMEMS to press on despite FDA setback

The chief executive of CardioMEMS said Friday that the company intends to keep moving forward despite a setback with the Food and Drug Administration over a new heart failure monitoring system.

Updated: December 09, 2011, - 09:12 PM

FDA, med-tech leaders seek accord

The industry and the agency want ways to speed up development and approval of new devices without cutting corners on safety.

Updated: December 07, 2011, - 09:05 PM

Wanted: Top ideas to help a medical device get off ground

Competition at Carlson School of Management gives students a look at challenges facing industry.

Updated: December 02, 2011, - 08:32 PM

St. Jude finds more trouble with wires on Riata defibrillator leads

Wires from a discontinued defibrillator lead sometimes poked through the outer coating of cables.

Updated: November 30, 2011, - 09:01 PM

Medtronic surpasses estimates

Sales increased 6 percent despite revenue shortfalls in defibrillators and spinal products.

Updated: November 22, 2011, - 08:34 PM

Result Per Page

ADVERTISEMENT

Connect with twitterConnect with facebookConnect with Google+Connect with PinterestConnect with PinterestConnect with RssfeedConnect with email newsletters
Search by category

ADVERTISEMENT

ADVERTISEMENT

ADVERTISEMENT

ADVERTISEMENT